Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

DURECT Corp (NASDAQ:DRRX)

1.40
Delayed Data
As of Sep 28
 +0.01 / +0.72%
Today’s Change
0.99
Today|||52-Week Range
2.70
-36.65%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Pharmaceuticals: Other
MARKET CAP
$191.0M

Company Description

DURECT Corp. is a specialty pharmaceutical company, which engages in development of pharmaceutical products for pain and chronic diseases based on its proprietary drug delivery technology platforms. It manufactures and sells osmotic pumps used in laboratory research, and designs, develops and manufactures a wide range of biodegradable polymers and excipients for pharmaceutical and medical device clients for use as raw materials in their products. The company also conducts research and development of pharmaceutical products in collaboration with third party pharmaceutical and biotechnology companies. DURECT was founded by James E. Brown and Felix Theeuwe on February 6, 1998 and is headquartered in Cupertino, CA.

Contact Information

DURECT Corp.
10260 Bubb Road
Cupertino California 95014-4166
P:(408) 777-1417
Investor Relations:
(408) 777-4936

Employees

Shareholders

Other institutional37.19%
Individual stakeholders21.72%
Mutual fund holders12.75%

Top Executives

Felix TheeuwesChairman & Chief Scientific Officer
James E. BrownPresident, Chief Executive Officer & Director
Judy JoiceSenior VP-Operations & Corporate Quality Assurance
Matthew J. HoganChief Financial Officer & Chief Accounting Officer
Wei Qi LinVice President-Research & Development